Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,170.00p
   
  • Change Today:
    -30.00p
  • 52 Week High: 1,456.00
  • 52 Week Low: 932.00
  • Currency: UK Pounds
  • Shares Issued: 50.17m
  • Volume: 9,850
  • Market Cap: 586.98m

Ergomed Overview

Ergomed is a global provider of expert, high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Ergomed Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 47.62 (4.45) 4.20p 43.7 n/a -38% n/a 0.0%
31-Dec-18 54.11 (10.77) (20.00)p n/a n/a n/a n/a 0.0%
31-Dec-19 68.25 4.99 19.90p 19.7 n/a n/a n/a 0.0%
31-Dec-20 86.39 12.63 25.80p 40.9 1.4 +30% n/a 0.0%
31-Dec-21 118.58 14.26 41.10p 36.5 0.6 +59% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Ergomed Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 161.13 27.27 46.47p 25.8 1.7 +15% n/a 0.0%
31-Dec-24 179.21 32.14 52.85p 22.7 1.7 +14% 0.17p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Ergomed Company Announcements

Jonathan Curtain appointed CFO 25-Jan-2023 07:00 RNS
Ergomed 2022 Trading Update 25-Jan-2023 07:00 RNS
Holding(s) in Company 20-Jan-2023 17:23 RNS

Latest Ergomed Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Ergomed Market Data

Currency UK Pounds
Share Price 1,170.00p
Change Today -30.00p
% Change -2.50 %
52 Week High 1,456.00
52 Week Low 932.00
Volume 9,850
Shares Issued 50.17m
Market Cap 586.98m

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
57.49% above the market average57.49% above the market average57.49% above the market average57.49% above the market average57.49% above the market average
80.33% above the sector average80.33% above the sector average80.33% above the sector average80.33% above the sector average80.33% above the sector average
Income Not Available
Growth
75.38% above the market average75.38% above the market average75.38% above the market average75.38% above the market average75.38% above the market average
84.62% above the sector average84.62% above the sector average84.62% above the sector average84.62% above the sector average84.62% above the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 1
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 31-Jan-2023

Time Volume / Share Price
10:53 670 @ 1,164.00p
10:40 18 @ 1,170.00p
10:24 192 @ 1,170.00p
10:24 16 @ 1,170.00p
10:24 167 @ 1,170.00p

Ergomed Key Personnel

CFO Richard Barfield

Top of Page